Literature DB >> 25826780

MicroRNA profiling of CD3+ CD56+ cytokine-induced killer cells.

Wenju Wang1, Ruhong Li1, Mingyao Meng1, Chuanyu Wei1, Yanhua Xie1, Yayong Zhang2, Lihong Jiang2, Ruiyi Dong1, Chunhui Wang1, Yiming Zhong1, Fang Yang3, Weiwei Tang1, Xingfang Jin1, Baohua Liu4, Zongliu Hou1.   

Abstract

Studies have proven that IL-2 and IL-15 showed contrasting roles during CIK cells preparation. By employing microarray, we analyzed miRNA expression profiles of PBMC, CIKIL-2 and CIKIL-15. Advanced bioinformatic analyses were performed to explore the key miRNAs which may regulate cell proliferation and anti-tumor activity of CIK. We identified 261 differentially expressed miRNAs (DEMs) between PBMC and CIKIL-2, and 249 DEMs between PBMC and CIKIL-15. MiR-143-3p/miR-145-5p was miRNA cluster which may positively regulate cell proliferation. In contrast, miR-340-5p/miR-340-3p cluster may negatively regulate cell proliferation via induction apoptosis, which may cause decreased cell proliferation capacity of CIKIL-2. MiRNA-target interaction analysis indicated that 10 co-downregulated miRNAs may synergistically turn on the expression of a pool of tumor cytotoxic genes in CIK cells. The DEMs between CIKIL-2 and CIKIL-15 may contribute to enhanced tumor cytotoxic capacity of CIKIL-2. Importantly, we found that repressed miR-193a-5p may regulate the expressions of inhibitory receptor KLRD1. The results of the validation assay have shown that KLRD1 were upregulated in CIK cells. Our findings have provided new insights into mechanisms of CIK cells production and tumor cytotoxic function, and shed light on their safety for clinical trial.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25826780      PMCID: PMC5380330          DOI: 10.1038/srep09571

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  42 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  AACR Cancer Progress Report 2013.

Authors:  Charles L Sawyers; Cory Abate-Shen; Kenneth C Anderson; Anna Barker; Jose Baselga; Nathan A Berger; Margaret Foti; Ahmedin Jemal; Theodore S Lawrence; Christopher I Li; Elaine R Mardis; Peter J Neumann; Drew M Pardoll; George C Prendergast; John C Reed; George J Weiner
Journal:  Clin Cancer Res       Date:  2013-09-16       Impact factor: 12.531

Review 4.  The role of microRNAs in the control of innate immune response in cancer.

Authors:  Simon Jasinski-Bergner; Ofer Mandelboim; Barbara Seliger
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

5.  SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells.

Authors:  Charlotte Viant; Aurore Fenis; Gaëtan Chicanne; Bernard Payrastre; Sophie Ugolini; Eric Vivier
Journal:  Nat Commun       Date:  2014-10-30       Impact factor: 14.919

Review 6.  Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway.

Authors:  Erika Cretney; Kazuyoshi Takeda; Mark J Smyth
Journal:  Int J Biochem Cell Biol       Date:  2006-10-07       Impact factor: 5.085

Review 7.  Human natural killer cells: origin, receptors, function, and clinical applications.

Authors:  Lorenzo Moretta; Elisa Montaldo; Paola Vacca; Genny Del Zotto; Francesca Moretta; Pietro Merli; Franco Locatelli; Maria Cristina Mingari
Journal:  Int Arch Allergy Immunol       Date:  2014-08-26       Impact factor: 2.749

8.  Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.

Authors:  Kuldeep S Cheent; Khaleel M Jamil; Sorcha Cassidy; Mengya Liu; Berenice Mbiribindi; Arend Mulder; Frans H J Claas; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

9.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

Review 10.  MicroRNA: implications for cancer.

Authors:  Stefanie Sassen; Eric A Miska; Carlos Caldas
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064

View more
  5 in total

1.  microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.

Authors:  Shan Pan; Mengyu Li; Haibo Yu; Zhiguo Xie; Xia Li; Xianlan Duan; Gan Huang; Zhiguang Zhou
Journal:  Acta Diabetol       Date:  2020-08-20       Impact factor: 4.280

2.  Early first trimester peripheral blood cell microRNA predicts risk of preterm delivery in pregnant women: Proof of concept.

Authors:  Edward E Winger; Jane L Reed; Xuhuai Ji
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

3.  The downregulation of putative anticancer target BORIS/CTCFL in an addicted myeloid cancer cell line modulates the expression of multiple protein coding and ncRNA genes.

Authors:  Evgeny Teplyakov; Qiongfang Wu; Jian Liu; Elena M Pugacheva; Dmitry Loukinov; Abdelhalim Boukaba; Victor Lobanenkov; Alexander Strunnikov
Journal:  Oncotarget       Date:  2017-09-02

4.  Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies.

Authors:  Yang Yang; Run-Qing Wang; Yi-Ming Zhong; Ming-Yao Meng; Yi-Yi Zhao; Li-Rong Yang; Lin Li; Zong-Liu Hou
Journal:  J Healthc Eng       Date:  2021-09-08       Impact factor: 2.682

5.  Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma.

Authors:  Yong-Bo Chen; Liang Gao; Jin-Dong Zhang; Jiang Guo; Ping-Hong You; Liang-You Tang; Ying-Wen Liu
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.